eClinical Development Advisor - eCOA, RTSM, Telemedicine, eConsent, Supplies, EDC - Signant Health
In the light of recent draft guidances from FDA on core patient-reported outcomes (PROs) in cancer trials, and on dose optimization in oncology drug development (resulting from the Project Optimus initiative) – thoughtful collection and interpretation of patient experience data in oncology clinical research is becoming even more critical. 💡 Explore use cases and gain practical tips for implementing PROMs throughout oncology in our webinar on: ✍ 8th February at 4pm GMT https://bit.ly/47mhvQZ
Explore use cases and gain practical tips for implementing PROMs throughout #oncology drug development (from early phase to phase III) in our #webinar Feb. 8. Secure your spot today: https://bit.ly/47mhvQZ